For primary pancreatic tumors, late stage (III-IV) PDA demonstrated higher ICOS-PD-1-CD127hiCD8+ (C12) and CD4+ T cells (C10) compared to early stage PDA tumors (Stage I-II) (Figure 5 and Supplementary Figure 5). This evidence concerns the gene ICOS and Patent ductus arteriosus.